Emma Colliver
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Cancer Genomics and Diagnostics 20
-
- Lung Cancer Treatments and Mutations 6
- Ferroptosis and cancer prognosis 2
- Co-authors
- Charles Swanton (6 shared papers)Kerstin Haase (3 shared papers)Tom L. Kaufmann (3 shared papers)Thomas B.K. Watkins (3 shared papers)Peter Van Loo (3 shared papers)Roland F. Schwarz (3 shared papers)Darlan Conterno Minussi (2 shared papers)Marina Petković (2 shared papers)
- Journals
- Nature (8 papers)Nature Communications (5 papers)Nature Cancer (4 papers)Nature Medicine (3 papers)Nature Genetics (2 papers)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
Emma Colliver
29 papers receiving 2.0k citations
Emma Colliver's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 647
- Oncology 529
- Pulmonary and Respiratory Medicine 485
- Immunology 254
- Health, Toxicology and Mutagenesis 154
Countries citing papers authored by Emma Colliver
This map shows the geographic impact of Emma Colliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Colliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Colliver more than expected).
Fields of papers citing papers by Emma Colliver
This network shows the impact of papers produced by Emma Colliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Colliver. The network helps show where Emma Colliver may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Colliver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lung adenocarcinoma promotion by air pollutants Hit paper breakdown → | 2023 | 528 |
| 2 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Hit paper breakdown → | 2023 | 255 |
| 3 | The evolution of lung cancer and impact of subclonal selection in TRACERx Hit paper breakdown → | 2023 | 188 |
| 4 | The evolution of non-small cell lung cancer metastases in TRACERx Hit paper breakdown → | 2023 | 154 |
| 5 | 2023 | 138 | |
| 6 | 2022 | 92 | |
| 7 | 2023 | 81 | |
| 8 | 2024 | 81 | |
| 9 | 2020 | 73 | |
| 10 | 2023 | 71 | |
| 11 | 2022 | 69 | |
| 12 | Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma Hit paper breakdown → | 2025 | 62 |
| 13 | 2021 | 51 | |
| 14 | 2021 | 51 | |
| 15 | 2024 | 28 | |
| 16 | 2024 | 25 | |
| 17 | 2024 | 22 | |
| 18 | 2023 | 22 | |
| 19 | 2022 | 14 | |
| 20 | 2022 | 13 |
About Emma Colliver
Emma Colliver is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Immunology, Oncology and Molecular Biology, having authored 30 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (6 papers), RNA modifications and cancer (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Genomics and Phylogenetic Studies (3 papers), CAR-T cell therapy research (3 papers), Immune cells in cancer (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (647 citations), Oncology (529 citations), Pulmonary and Respiratory Medicine (485 citations), Immunology (254 citations) and Health, Toxicology and Mutagenesis (154 citations). Emma Colliver has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Charles Swanton, Kerstin Haase, Tom L. Kaufmann, Thomas B.K. Watkins, Peter Van Loo, Roland F. Schwarz, Darlan Conterno Minussi, Marina Petković, Maxime Tarabichi and Nicholas E. Navin. Their work appears in journals such as Nature, Nature Communications, Nature Cancer, Nature Medicine and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.